Shop

The Hartford Courant examines possible conflicts of interest inherent in academic medical research now that such research is funded more by corporate, rather than government, dollars. The Courant reveals that many academics at such schools as Harvard and UCLA receive their funding from the very companies that designed the drugs they are studying. Thus, there is some question as to the trustworthiness of the data these academics collect. "A Courant review of more than 40 recently developed drugs, as well as interviews with dozens of researchers across the nation, has found that scientists are asking questions -- and getting answers -- that neatly fit the agenda of their corporate sponsors."